RxDoctor Payments Data

Stephen Melnick, DO

Clinical Cardiac Electrophysiology · Mechanicsburg, PANPI 1497132641

Payments from drug & device makers

$6,931in general payments, 2019–2025

Across 181 payments — averaging $38.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Biotronik Inc.$2K
  • Boston Scientific$454
  • Medtronic$397
  • Atricure, Inc.$314
  • Philips North America LLC$111
  • plus $313 from 9 others

What the payments were for

  • Travel & lodging$2,79840%
  • Food & beverage$3,61752%
  • Education$5177%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,931 in reported general payments places this provider in the 20th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$162,009
Medicare patients
722
Services billed
2,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban216$252,003
MultaqDronedarone Hcl32$49,555
EntrestoSacubitril/Valsartan33$29,413
XareltoRivaroxaban25$24,112
JardianceEmpagliflozin16$23,912
Metoprolol Succinate178$3,608
Amiodarone Hcl153$2,969
Flecainide Acetate55$2,708
Dabigatran EtexilateDabigatran Etexilate Mesylate12$1,992
Diltiazem 24hr Er (Cd)Diltiazem Hcl44$1,104
Atorvastatin Calcium54$826
Rosuvastatin Calcium28$775
Digoxin27$604
ClopidogrelClopidogrel Bisulfate36$507
Amlodipine Besylate35$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$252,003216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

Other clinical cardiac electrophysiology in Mechanicsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →